SXSW: Biden details Moonshot program to battle cancer

Former Vice President Joe Biden spoke Sunday at SXSW about the White House Cancer Moonshot program’s progress in the fight against cancer, and called for innovators in the audience to use their ingenuity to engineer solutions. The Cancer Moonshot program was established in early 2016 to accelerate innovation in the field of cancer research.

Hart to Heart: The fight to save Nicholas’ life

The battle against B Cell High Risk Acute Lymphoblastic Leukemia has been beyond challenging for 12-year-old Nicholas Childers of Savannah. The Hancock Day School seventh-grader has endured multiple medical complications during rigorous treatment since being diagnosed with B-ALL in 2015.

TiGenix Receives Positive Feedback from the FDA on Cx601 Global Phase III Trial Protocol

On August 2015, TiGenix received the FDA endorsement of a Special Protocol Assessment for a pivotal Phase III study for Biologics License Application in the U.S. Since the granting of the SPA, further confirmatory positive results have been obtained from the European Phase III study of Cx601 , the largest randomized study performed so far in Crohn’s disease patients with complex perianal fistulas. Subsequently, TiGenix submitted a Marketing Authorization Application to the European Medicines Agency in March 2016.

Heston Blumenthal on his over-active mind

Heston Blumenthal’s head-spinningly exotic dishes have made him the nutty professor of British gastronomy. Now the inventor of snail porridge tells Event how his over-active mind has driven him to boiling point Heston Blumenthal just can’t sit still.

Smokers say graphic warnings on cigaret…

Sung Jong-tae, 35, a heavy smoker for the past 15 years, has tried almost everything there is to quit smoking, but his efforts have been in vain. “I am well aware, more than anybody else, of the detrimental effects of smoking, having a 3-year-old daughter at home.

Xenex Secures $38 Million In Funding Led By & Company??’s…

February 24, 2017 – Xenex Disinfection Services, the manufacturer of LightStrike Germ-Zapping Robotsa , today announced the investment of $38 million in a funding round led by Essex Woodlands , one of the country’s leading healthcare private equity firms. The financing, which includes new participation from Piper Jaffray Merchant Banking and continued investment from existing investors Malin Corporation and Tectonic Ventures, will be used for growing its sales force, product development, scientific research and international expansion.

ITL Group celebrates 40 years of medical device manufacturing

Founded on 25th February 1977, the design and manufacturing partner for leading life-saving medical technology has enjoyed success on a global scale. As the “go-to” contract design, development, manufacturing and consultancy partner for some of the biggest names in MedTech, the ITL Group has established operations in Shanghai, China and Richmond, Virginia, USA, in addition to their headquarters in Ashford, Kent, UK.

Stem cell transplants may help some with multiple sclerosis

Stem cell transplants may halt the progression of aggressive multiple sclerosis in nearly half of those with the debilitating disease, but picking the right patients for the treatment is key, a new study suggests. Specifically, younger patients with a relapsing form of MS who were not severely disabled and who hadn’t found relief with other treatments fared better than others over five years, the international team of researchers found.

Researchers create novel model that reveals cellular, molecular events driving leukemia progression

Mount Sinai researchers have created a novel model that shows the step-by-step progression from normal blood cells to leukemia and its precursor diseases, creating replicas of the stages of the disease to test the efficacy of therapeutic interventions at each stage, according to a study to be published in Cell Stem Cell. This research marked the first time scientists have been able to transplant leukemia from humans to a test tube and then into mice for study, a landmark feat that will allow for valuable research to help find therapies for blood cancer patients in the future.

Sydney chiropractor Hance Limboro fined $27,500 for cancer cure advertisements

The online advertisement proclaimed: “By having a regular visit to a chiropractor, people can rest assured that they are prevented from having cancer.” Sydney chiropractor Hance Limboroa is the first person in the country to be prosecuted by the Australian Health Practitioner Regulation Agency for misleading advertising, relating to a series of ads on a website called Cancer Cure Sydney.

Newly discovered breast stem cells wake up when exposed to ovarian hormones

Walter and Eliza Hall Institute researchers have used advanced cellular, bioinformatics and imaging technology to reveal a long-lived type of stem cell in the breast that is responsible for the growth of the mammary glands during pregnancy. The newly discovered stem cells, which respond to the ‘ovarian hormones’ progesterone and oestrogen, may also be linked to a high-risk form of breast cancer.

Newly discovered breast stem cells wake up when exposed to ovarian hormones

Walter and Eliza Hall Institute researchers have used advanced cellular, bioinformatics and imaging technology to reveal a long-lived type of stem cell in the breast that is responsible for the growth of the mammary glands during pregnancy. The newly discovered stem cells, which respond to the ‘ovarian hormones’ progesterone and oestrogen, may also be linked to a high-risk form of breast cancer.

Can banking baby teeth treat diabetes?

When she was just 11 months old, Billie Sue Wozniak’s daughter Juno was diagnosed with type 1 diabetes, an autoimmune disease that affects 1.25 million people and approximately 200,000 children under age 20 in the United States. The disease had affected several members of Billie Sue’s family, including her uncle, who passed away at the age of 30. “My first thought was, ‘Her life is going to be short,'” the 38-year-old from Reno, Nevada recalled.

Why Intuitive Surgical Is Increasing R&D Spending by Over 30%

One of the more surprising aspects was the announcement that it planned to increase the amount it spends on research and development in 2017 by an additional $80 million dollars, a full 30% higher than in 2016. Considering that it had already increased R&D spending in 2016 by over 20%, this represents a significant additional investment.

How abortion ushered in modern medicine

It seems like debates over vaccines are fairly recent phenomenon, but in truth, medical progress has always been fraught with controversy, competition, and ethical conundrums. In her new book “The Vaccine Race: Science, Politics, and the Human Costs of Defeating Disease,” author Meredith Wadman explores the story behind the creation of rubella vaccine – a medical breakthrough that has helped generations of Americans have healthier childhoods.

Covered California enrolls 368,000 new Obamacare customers

The number of people signing up for a Covered California health plan is down in the first enrollment period since President Donald Trump was elected with a pledge to repeal his predecessor’s signature health care law, figures released Monday show. Just over 386,000 new people signed up for coverage through the health insurance marketplace created under the Affordable Care Act.

Algorithms crunch calls to health insurer for signs of disease

Did your voice give it away? US start-up Canary Speech is developing deep-learning algorithms to detect if people have neurological conditions like Parkinson’s or Alzheimer’s disease just by listening to the sound of their voice. And it’s found a controversial source of audio data to train its algorithms on: phone calls to a health insurer.

Mission Bio Receives Investment from Life Science Angels

Mission Bio, Inc. announced today that it has secured funding from U.S. top ranked angel investment group Life Science Angels in a seed round to commercialize its high throughput single-cell genomics system. Mission Bio is developing a microfluidic, droplet-based platform to enable critical advances in diseases like cancer, where elucidating heterogeneity in cell populations is essential.

World’s First Stem-Cell Study for Cystic Fibrosis

A 39-year-old man with cystic fibrosis has made history by becoming the first person in the world to receive human adult stem cells in a new study that researchers hope will some day lead to the development of a therapy to reduce the inflammation and infection caused by CF. The study is being conducted at University Hospitals Rainbow Babies & Children’s Hospital in Cleveland, Ohio.

Link between human body clock and breast cancer risk discovered

Biologists in Britain have discovered a link between the human body clock and the risk of breast cancer, the University of Manchester announced Tuesday. Chinese-born Dr. Qing-Jun Meng and Professor Charles Streuli have discovered that breast tissues have 24-hour body clocks, and that several hundred genes are regulated in a daily cycle.